首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >From the Cover: Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
【2h】

From the Cover: Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions

机译:从封面开始:增强子α和β(FAM150)是受体酪氨酸激酶ALK和LTK的配体:配体-受体相互作用的层次和特异性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Receptor tyrosine kinases (RTKs) are a class of cell surface receptors that, upon ligand binding, stimulate a variety of critical cellular functions. The orphan receptor anaplastic lymphoma kinase (ALK) is one of very few RTKs that remain without a firmly established protein ligand. Here we present a novel cytokine, FAM150B, which we propose naming augmentor-α (AUG-α), as a ligand for ALK. AUG-α binds ALK with high affinity and activates ALK in cells with subnanomolar potency. Detailed binding experiments using cells expressing ALK or the related receptor leukocyte tyrosine kinase (LTK) demonstrate that AUG-α binds and robustly activates both ALK and LTK. We show that the previously established LTK ligand FAM150A (AUG-β) is specific for LTK and only weakly binds to ALK. Furthermore, expression of AUG-α stimulates transformation of NIH/3T3 cells expressing ALK, induces IL-3 independent growth of Ba/F3 cells expressing ALK, and is expressed in neuroblastoma, a cancer partly driven by ALK. These experiments reveal the hierarchy and specificity of two cytokines as ligands for ALK and LTK and set the stage for elucidating their roles in development and disease states.
机译:受体酪氨酸激酶(RTK)是一类细胞表面受体,在结合配体后会刺激多种关键的细胞功能。孤儿受体间变性淋巴瘤激酶(ALK)是极少数没有牢固建立的蛋白质配体的RTK之一。在这里,我们介绍了一种新型的细胞因子FAM150B,我们提议将增强子α(AUG-α)命名为ALK的配体。 AUG-α以高亲和力结合ALK,并以亚纳摩尔能力激活细胞中的ALK。使用表达ALK或相关受体白细胞酪氨酸激酶(LTK)的细胞进行的详细结合实验表明,AUG-α结合并牢固激活ALK和LTK。我们表明,先前建立的LTK配体FAM150A(AUG-β)对LTK具有特异性,并且仅与ALK弱结合。另外,AUG-α的表达刺激表达ALK的NIH / 3T3细胞的转化,诱导表达ALK的Ba / F3细胞的IL-3非依赖性生长,并在神经母细胞瘤中表达,神经母细胞瘤是部分由ALK驱动的癌症。这些实验揭示了两种细胞因子作为ALK和LTK配体的层次和特异性,并为阐明它们在发育和疾病状态中的作用奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号